|Mr. Douglas E. Godshall M.B.A.||Pres, CEO & Director||1.4M||29.81M||1965|
|Mr. Daniel Puckett MBA||CFO, Principal Financial Officer & Sec.||658.71k||5.49M||1964|
|Mr. Isaac Zacharias||Chief Commercial Officer||679.54k||11.58M||1975|
|Mr. Daniel Hawkins||Founder and Sr. Advisor||N/A||N/A||1967|
|Mr. John M. Adams||Co-Founder and Technical Advisor||N/A||N/A||1947|
|Mr. Mike Maszy||VP of Operations||N/A||N/A||N/A|
|Ms. Trinh Phung||Chief Accounting Officer, Principal Accounting Officer & VP of Fin.||N/A||N/A||1978|
|Ms. Debbie Kaster||VP of Investor Relations||N/A||N/A||N/A|
|Mr. Hajime Tada J.D.||Gen. Counsel & Sec.||N/A||N/A||N/A|
|Mr. Rob Williamson Jr.||VP of Sales||N/A||N/A||N/A|
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
ShockWave Medical, Inc.’s ISS Governance QualityScore as of November 28, 2022 is 9. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 8; Compensation: 10.